Cargando…

Assessment of the Potential Impact and Cost-effectiveness of Self-Testing for HIV in Low-Income Countries

BACKGROUND: Studies have demonstrated that self-testing for human immunodeficiency virus (HIV) is highly acceptable among individuals and could allow cost savings, compared with provider-delivered HIV testing and counseling (PHTC), although the longer-term population-level effects are uncertain. We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cambiano, Valentina, Ford, Deborah, Mabugu, Travor, Napierala Mavedzenge, Sue, Miners, Alec, Mugurungi, Owen, Nakagawa, Fumiyo, Revill, Paul, Phillips, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2015
Materias:	Major Articles and Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4512606/ https://www.ncbi.nlm.nih.gov/pubmed/25767214 http://dx.doi.org/10.1093/infdis/jiv040

Ejemplares similares

Cost-Effectiveness of HIV Drug Resistance Testing to Inform Switching to Second Line Antiretroviral Therapy in Low Income Settings
por: Phillips, Andrew, et al.
Publicado: (2014)

Identifying Key Drivers of the Impact of an HIV Cure Intervention in Sub-Saharan Africa
por: Phillips, Andrew N., et al.
Publicado: (2016)

Modelling the Potential Population Impact and Cost-Effectiveness of Self-Testing for HIV: Evaluation of Data Requirements
por: Cambiano, Valentina, et al.
Publicado: (2014)

Cost Effectiveness of Potential ART Adherence Monitoring Interventions in Sub-Saharan Africa
por: Phillips, Andrew N, et al.
Publicado: (2016)

Point-of-Care Viral Load Testing for Sub-Saharan Africa: Informing a Target Product Profile
por: Phillips, Andrew N., et al.
Publicado: (2016)

Impact of HIV Drug Resistance on HIV/AIDS-Associated Mortality, New Infections, and Antiretroviral Therapy Program Costs in Sub–Saharan Africa
por: Phillips, Andrew N., et al.
Publicado: (2017)

Potential Impact and Cost-Effectiveness of Condomless-Sex–Concentrated PrEP in KwaZulu-Natal Accounting for Drug Resistance
por: Phillips, Andrew N, et al.
Publicado: (2019)

Projected Lifetime Healthcare Costs Associated with HIV Infection
por: Nakagawa, Fumiyo, et al.
Publicado: (2015)

Systematic Review and Meta-Analysis of Cost-effectiveness of Rotavirus Vaccine in Low-Income and Lower-Middle-Income Countries
por: Haider, Sabbir, et al.
Publicado: (2019)

Increased HIV Incidence in Men Who Have Sex with Men Despite High Levels of ART-Induced Viral Suppression: Analysis of an Extensively Documented Epidemic
por: Phillips, Andrew N., et al.
Publicado: (2013)

Cost‐per‐diagnosis as a metric for monitoring cost‐effectiveness of HIV testing programmes in low‐income settings in southern Africa: health economic and modelling analysis
por: Phillips, Andrew N, et al.
Publicado: (2019)

Cost-Effectiveness of Tenofovir Instead of Zidovudine for Use in First-Line Antiretroviral Therapy in Settings without Virological Monitoring
por: von Wyl, Viktor, et al.
Publicado: (2012)

Reflecting the real value of health care resources in modelling and cost-effectiveness studies—The example of viral load informed differentiated care
por: Revill, Paul, et al.
Publicado: (2018)

Engagement in HIV services over time among young women who sell sex in Zimbabwe
por: Napierala, Sue, et al.
Publicado: (2022)

Potential Future Impact of a Partially Effective HIV Vaccine in a Southern African Setting
por: Phillips, Andrew N., et al.
Publicado: (2014)

Cost‐effectiveness of routine viral load monitoring in low‐ and middle‐income countries: a systematic review
por: Barnabas, Ruanne V, et al.
Publicado: (2017)

A Review of Self-Testing for HIV: Research and Policy Priorities in a New Era of HIV Prevention
por: Napierala Mavedzenge, Sue, et al.
Publicado: (2013)

Preferences for HIV testing services among men who have sex with men in the UK: A discrete choice experiment
por: Miners, Alec, et al.
Publicado: (2019)

90‐90‐90 by 2020? Estimation and projection of the adult HIV epidemic and ART programme in Zimbabwe – 2017 to 2020
por: Bansi‐Matharu, Loveleen, et al.
Publicado: (2018)

Potential impact on HIV incidence of higher HIV testing rates and earlier antiretroviral therapy initiation in MSM
por: Phillips, Andrew N., et al.
Publicado: (2015)

Delayed Tuberculosis Treatment and Cost of Care in a Low-Incidence Country
por: O’Connell, James, et al.
Publicado: (2022)

Cost Burden of Rigid Internal Fixation in Craniomaxillofacial Trauma Care in Low‐ and Middle‐Income Countries
por: Shaye, David A., et al.
Publicado: (2023)

A mixed methods study on effectiveness and appropriateness of face shield use as COVID-19 PPE in middle income countries
por: Brainard, Julii, et al.
Publicado: (2022)

Distribution of Serotypes Causing Invasive Pneumococcal Disease in Children From High-Income Countries and the Impact of Pediatric Pneumococcal Vaccination
por: Grant, Lindsay R, et al.
Publicado: (2022)

Promoting Partner Testing and Couples Testing through Secondary Distribution of HIV Self-Tests: A Randomized Clinical Trial
por: Masters, Samuel H., et al.
Publicado: (2016)

Early Antiretroviral Therapy Not Associated With Higher Cryptococcal Meningitis Mortality in People With Human Immunodeficiency Virus in High-Income Countries: An International Collaborative Cohort Study
por: Ingle, Suzanne M, et al.
Publicado: (2023)

Household Costs of Diarrhea by Etiology in 7 Countries, The Global Enterics Mulitcenter Study (GEMS)
por: Zimmermann, Marita, et al.
Publicado: (2019)

Direct-Acting Antiviral Treatment for Hepatitis C Genotypes Uncommon in High-Income Countries: A Dutch Nationwide Cohort Study
por: Isfordink, Cas J, et al.
Publicado: (2021)

Antibiotic Treatment Duration for Community-Acquired Pneumonia in Outpatient Children in High-Income Countries—A Systematic Review and Meta-Analysis
por: Kuitunen, Ilari, et al.
Publicado: (2022)

Systematic Literature Review of Risk Factors for Poor Outcomes Among Adults With Respiratory Syncytial Virus Infection in High-Income Countries
por: Njue, Annete, et al.
Publicado: (2023)

Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study
por: Phillips, Andrew N, et al.
Publicado: (2018)

Finger Prick Dried Blood Spots for HIV Viral Load Measurement in Field Conditions in Zimbabwe
por: Mavedzenge, Sue Napierala, et al.
Publicado: (2015)

Setting a Course for Preventing Hepatitis E in Low and Lower-Middle-Income Countries: A Systematic Review of Burden and Risk Factors
por: Koyuncu, Aybüke, et al.
Publicado: (2021)

Stopping Oral Polio Vaccine (OPV) After Defeating Poliomyelitis in Low- and Middle-Income Countries: Harmful Unintended Consequences? Review of the Nonspecific Effects of OPV
por: Aaby, Peter, et al.
Publicado: (2022)

A qualitative study of secondary distribution of HIV self-test kits by female sex workers in Kenya
por: Maman, Suzanne, et al.
Publicado: (2017)

Cost-effectiveness of screening for HIV in primary care: a health economics modelling analysis
por: Baggaley, Rebecca F, et al.
Publicado: (2017)

Economic Costs of Violence Against Women and Girls in Low- and Middle-Income Countries: A Pilot Study on Management’s Outlook
por: Chadha, Mrinal, et al.
Publicado: (2022)

Body Mass Index and Poor Self-Rated Health in 49 Low-Income and Middle-Income Countries, By Sex, 2002–2004
por: Wang, Aolin, et al.
Publicado: (2015)

The Use of Cost-Effectiveness Thresholds for Evaluating Health Interventions in Low- and Middle-Income Countries From 2015 to 2020: A Review
por: Kazibwe, Joseph, et al.
Publicado: (2022)

Investment Success in Public Health: An Analysis of the Cost-Effectiveness and Cost-Benefit of the Global Programme to Eliminate Lymphatic Filariasis
por: Turner, Hugo C., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4f4v2qe9e5kqjgauk47k5nthnv